RU2599718C2 - Макролидное производное, замещенное по с-4''-положению - Google Patents

Макролидное производное, замещенное по с-4''-положению Download PDF

Info

Publication number
RU2599718C2
RU2599718C2 RU2013142898/04A RU2013142898A RU2599718C2 RU 2599718 C2 RU2599718 C2 RU 2599718C2 RU 2013142898/04 A RU2013142898/04 A RU 2013142898/04A RU 2013142898 A RU2013142898 A RU 2013142898A RU 2599718 C2 RU2599718 C2 RU 2599718C2
Authority
RU
Russia
Prior art keywords
group
formula
alkyl group
substituted
compound
Prior art date
Application number
RU2013142898/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2013142898A (ru
Inventor
Томохиро СУГИМОТО
Наоки САСАМОТО
Дзун КУРОСАКА
Масато ХАЯСИ
Канако ЯМАМОТО
Масато КАСИМУРА
Ясунобу УСИКИ
Харухиса ОГИТА
Томоаки МИУРА
Кенити КАНЕМОТО
Коу КУМУРА
Сатоси ЙОСИДА
Кейдзи ТАМУРА
Еики СИТАРА
Original Assignee
Мейдзи Сейка Фарма Ко., Лтд.
Тайсо Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46721028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2599718(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Мейдзи Сейка Фарма Ко., Лтд., Тайсо Фармасьютикал Ко., Лтд. filed Critical Мейдзи Сейка Фарма Ко., Лтд.
Publication of RU2013142898A publication Critical patent/RU2013142898A/ru
Application granted granted Critical
Publication of RU2599718C2 publication Critical patent/RU2599718C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
RU2013142898/04A 2011-02-21 2012-02-20 Макролидное производное, замещенное по с-4''-положению RU2599718C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011-034578 2011-02-21
JP2011034578 2011-02-21
PCT/JP2012/054677 WO2012115256A1 (en) 2011-02-21 2012-02-20 C-4" position substituted macrolide derivative

Publications (2)

Publication Number Publication Date
RU2013142898A RU2013142898A (ru) 2015-03-27
RU2599718C2 true RU2599718C2 (ru) 2016-10-10

Family

ID=46721028

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013142898/04A RU2599718C2 (ru) 2011-02-21 2012-02-20 Макролидное производное, замещенное по с-4''-положению

Country Status (35)

Country Link
US (1) US9139609B2 (enExample)
EP (1) EP2678349B1 (enExample)
JP (1) JP5687777B2 (enExample)
KR (1) KR20140008388A (enExample)
CN (1) CN103492404B (enExample)
AR (1) AR085286A1 (enExample)
AU (1) AU2012222267B2 (enExample)
BR (1) BR112013020118A2 (enExample)
CA (1) CA2827474A1 (enExample)
CL (1) CL2013002313A1 (enExample)
CO (1) CO6801737A2 (enExample)
CY (1) CY1117381T1 (enExample)
DK (1) DK2678349T3 (enExample)
ES (1) ES2566368T3 (enExample)
HR (1) HRP20160252T1 (enExample)
HU (1) HUE028245T2 (enExample)
IL (1) IL227663A (enExample)
IN (1) IN2013CN07459A (enExample)
ME (1) ME02475B (enExample)
MX (1) MX2013009585A (enExample)
MY (1) MY161451A (enExample)
NZ (1) NZ613956A (enExample)
PE (1) PE20140649A1 (enExample)
PH (1) PH12013501695B1 (enExample)
PL (1) PL2678349T3 (enExample)
RS (1) RS54635B1 (enExample)
RU (1) RU2599718C2 (enExample)
SA (1) SA112330287B1 (enExample)
SG (1) SG192655A1 (enExample)
SI (1) SI2678349T1 (enExample)
SM (1) SMT201600106B (enExample)
TW (1) TWI513704B (enExample)
UA (1) UA111191C2 (enExample)
WO (1) WO2012115256A1 (enExample)
ZA (1) ZA201305983B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103588833B (zh) * 2013-10-30 2016-08-17 北京科技大学 动物抗菌素泰拉霉素的制备方法
CN105085590A (zh) * 2014-05-16 2015-11-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) * 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 C-4"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN108610388B (zh) * 2016-12-12 2020-11-06 浙江京新药业股份有限公司 一种大环内酯的制备方法
CN109425666B (zh) * 2017-08-28 2022-07-08 广东东阳光药业有限公司 一种酰氯衍生物的lc-ms分析方法
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
TW202535873A (zh) 2019-09-26 2025-09-16 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物
CN111423482B (zh) * 2020-04-26 2023-01-17 梯尔希(南京)药物研发有限公司 一种同位素标记的红霉胺的合成方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999050276A1 (en) * 1998-03-27 1999-10-07 Abbott Laboratories 3',3'-n-bis-substituted macrolide lhrh antagonists
RU2144541C1 (ru) * 1995-12-08 2000-01-20 Руссель Юклаф Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
EA002440B1 (ru) * 1997-06-11 2002-04-25 Пфайзер Продактс Инк. С-4"-замещенные макролидные производные
RU2192427C2 (ru) * 1996-09-04 2002-11-10 Абботт Лаборэтриз Производные эритромицина, обладающие антибактериальной активностью, способ их получения (варианты), фармацевтическая композиция и способ регулирования бактериальной инфекции у млекопитающего
WO2008106224A1 (en) * 2007-02-28 2008-09-04 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5393743A (en) 1993-07-06 1995-02-28 Abbott Laboratories Erythromycin derivatives
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
BR0010938A (pt) * 1999-05-24 2002-03-19 Pfizer Prod Inc Derivados da 13-metil eritromicina
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
US20080203485A1 (en) 2007-02-28 2008-08-28 International Business Machines Corporation Strained metal gate structure for cmos devices with improved channel mobility and methods of forming the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2144541C1 (ru) * 1995-12-08 2000-01-20 Руссель Юклаф Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
RU2192427C2 (ru) * 1996-09-04 2002-11-10 Абботт Лаборэтриз Производные эритромицина, обладающие антибактериальной активностью, способ их получения (варианты), фармацевтическая композиция и способ регулирования бактериальной инфекции у млекопитающего
EA002440B1 (ru) * 1997-06-11 2002-04-25 Пфайзер Продактс Инк. С-4"-замещенные макролидные производные
WO1999050276A1 (en) * 1998-03-27 1999-10-07 Abbott Laboratories 3',3'-n-bis-substituted macrolide lhrh antagonists
WO2008106224A1 (en) * 2007-02-28 2008-09-04 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same

Also Published As

Publication number Publication date
RS54635B1 (sr) 2016-08-31
SA112330287B1 (ar) 2015-10-11
IN2013CN07459A (enExample) 2015-04-24
SI2678349T1 (sl) 2016-04-29
EP2678349B1 (en) 2016-01-13
TW201247693A (en) 2012-12-01
HRP20160252T1 (hr) 2016-04-22
EP2678349A1 (en) 2014-01-01
PH12013501695B1 (en) 2018-07-11
CY1117381T1 (el) 2017-04-26
US9139609B2 (en) 2015-09-22
JP5687777B2 (ja) 2015-03-18
CN103492404A (zh) 2014-01-01
BR112013020118A2 (pt) 2017-07-18
MX2013009585A (es) 2014-06-05
DK2678349T3 (en) 2016-03-07
HUE028245T2 (en) 2016-12-28
TWI513704B (zh) 2015-12-21
CA2827474A1 (en) 2012-08-30
US20140046043A1 (en) 2014-02-13
WO2012115256A1 (en) 2012-08-30
CN103492404B (zh) 2016-09-07
AU2012222267A1 (en) 2013-08-22
JP2014505723A (ja) 2014-03-06
PL2678349T3 (pl) 2016-06-30
SMT201600106B (it) 2016-04-29
AU2012222267B2 (en) 2016-07-07
CO6801737A2 (es) 2013-11-29
ZA201305983B (en) 2014-11-26
ES2566368T3 (es) 2016-04-12
IL227663A0 (en) 2013-09-30
EP2678349A4 (en) 2014-07-30
CL2013002313A1 (es) 2014-08-08
RU2013142898A (ru) 2015-03-27
KR20140008388A (ko) 2014-01-21
AR085286A1 (es) 2013-09-18
SG192655A1 (en) 2013-09-30
IL227663A (en) 2017-09-28
ME02475B (me) 2017-02-20
PH12013501695A1 (en) 2013-10-07
NZ613956A (en) 2014-07-25
UA111191C2 (uk) 2016-04-11
MY161451A (en) 2017-04-14
PE20140649A1 (es) 2014-06-25

Similar Documents

Publication Publication Date Title
RU2599718C2 (ru) Макролидное производное, замещенное по с-4''-положению
RU2455308C2 (ru) Макролидные производные
US8097708B2 (en) 10a-Azalide compound
JP5857008B2 (ja) C−4”位置換マクロライド誘導体を含有する医薬
US8299035B2 (en) 10a-azalide compound having 4-membered ring structure
JP7112963B2 (ja) セコマクロライド化合物
JP2014058507A (ja) 11位アミノ置換マクロライド誘導体
US8293715B2 (en) 10a-Azalide compound crosslinked at 10a- and 12-positions
HK1191338A (en) C-4"position substituted macrolide derivative
HK1191338B (en) C-4"position substituted macrolide derivative
JP2014058508A (ja) 9位オキシム置換マクロライド誘導体
HK1133037B (en) Macrolide derivative
HK1184162A (en) Macrolide derivatives

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180221